Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01961115
Title INCB024360 and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center




MELITAC 12.1 Peptide Vaccine

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University/Winship Cancer Institute Atlanta Georgia 30322 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from for the field